Jessup Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$819K Sell
890
-364
-29% -$369K 0.3% 38
2025
Q4
$1.35M Buy
1,254
+108
+9% +$103K 0.45% 36
2025
Q3
$874K Sell
1,146
-28
-2% -$20.8K 0.33% 36
2025
Q2
$915K Buy
1,174
+852
+265% +$662K 0.37% 39
2025
Q1
$266K Sell
322
-70
-18% -$58.2K 0.11% 63
2024
Q4
$303K Buy
392
+19
+5% +$15.7K 0.13% 57
2024
Q3
$331K Sell
373
-17
-4% -$15.3K 0.15% 48
2024
Q2
$353K Hold
390
0.15% 46
2024
Q1
$303K Buy
+390
New +$278K 0.13% 49
2023
Q1
Sell
-13,266
Closed -$4.85M 72
2022
Q4
$4.85M Buy
+13,266
New +$4.7M 3.08% 10

Other funds holding LLY

Jessup Wealth Management's LLY Position: Q1 2026 in Review

Jessup Wealth Management reduced its Eli Lilly (LLY) stake by 29% in Q1 2026, selling an estimated $369K and leaving 890 shares worth $819K. The position accounts for 0.3% of the portfolio, ranked #38.

Jessup Wealth Management first reported a position in LLY in Q4 2022 and has held it in 10 quarters since. The position peaked at $4.85M in Q4 2022. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Jessup Wealth Management held 890 shares of Eli Lilly worth $819K as of Q1 2026.
  • Jessup Wealth Management sold 364 Eli Lilly shares in Q1 2026, an estimated $369K.
  • Eli Lilly made up 0.3% of Jessup Wealth Management's portfolio in Q1 2026, its #38 holding.
  • Jessup Wealth Management first reported a position in Eli Lilly in Q4 2022 and has held it in 10 quarters since.
  • Jessup Wealth Management's Eli Lilly position peaked at $4.85M in Q4 2022.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Jessup Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.